Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer.

Autor: Øgaard N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Jensen SØ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Ørntoft MW; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Surgery, Gødstrup Hospital, Herning, Denmark., Demuth C; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Lyskjær I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Nesic M; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Therkildsen C; Gastro Unit, Surgical Section, Copenhagen University Hospital, Amager-Hvidovre, Denmark., Kleif J; Gastro Unit, Surgical Section, Copenhagen University Hospital, Amager-Hvidovre, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Gögenur M; Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark., Jørgensen LN; Digestive Disease Centre, Bispebjerg Hospital, Copenhagen, Denmark., Vilandt J; Department of Surgery, Nordsjællands Hospital, Hillerød, Denmark., Seidelin JB; Department of Gastroenterology and Hepatology, Herlev Hospital, Herlev, Denmark., Gotschalck KA; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.; Department of Surgery, Horsens Hospital, Horsens, Denmark., Jaensch C; Department of Surgery, Gødstrup Hospital, Herning, Denmark., Andersen B; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.; Department of Public Health Programs and University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark., Løve US; Department of Surgery, Viborg Hospital, Viborg, Denmark., Thorlacius-Ussing O; Clinical Cancer Research Center, Aalborg University, Aalborg, Denmark., Andersen PV; Department of Surgery, Odense University Hospital, Odense, Denmark., Kolbro T; Department of Surgery, Odense University Hospital, Svendborg, Denmark., Monti A; Department of Surgery, North Denmark Regional Hospital Hjørring, Hjørring, Denmark., Kildsig J; Department of Surgery, Copenhagen University Hospital, Herlev, Denmark., Bondeven P; Department of Surgery, Regional Hospital Randers, Randers, Denmark., Schlesinger NH; Digestive Disease Centre, Bispebjerg Hospital, Copenhagen, Denmark., Iversen LH; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.; Department of Surgery, Aarhus University Hospital, Aarhus, Denmark., Rasmussen M; Digestive Disease Centre, Bispebjerg Hospital, Copenhagen, Denmark., Gögenur I; Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark., Bramsen JB; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. cla@clin.au.dk.; Institute of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark. cla@clin.au.dk.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1707-1715. Date of Electronic Publication: 2024 Oct 10.

Incidence of late recurrence and second primary cancers 5-10 years after non-metastatic colorectal cancer.

Autor: Nors J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Gotschalck KA; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Surgery, Horsens Regional Hospital, Horsens, Denmark., Erichsen R; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.; Department of Surgery, Randers Regional Hospital, Randers, Denmark., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Jun 01; Vol. 154 (11), pp. 1890-1899. Date of Electronic Publication: 2024 Feb 07.

Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients.

Autor: Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Nesic M; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Reinert T; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Afterman D; C2i Genomics, Ltd., Haifa, Israel., Lauterman T; C2i Genomics, Ltd., Haifa, Israel., Kuzman M; C2i Genomics Inc., New York, NY 10014, USA., Gonzalez S; C2i Genomics Inc., New York, NY 10014, USA., Glavas D; C2i Genomics Inc., New York, NY 10014, USA., Smadback J; C2i Genomics Inc., New York, NY 10014, USA., Maloney D; C2i Genomics Inc., New York, NY 10014, USA., Levativ J; C2i Genomics Inc., New York, NY 10014, USA., Yahalom M; C2i Genomics Inc., New York, NY 10014, USA., Ptashkin R; C2i Genomics Inc., New York, NY 10014, USA., Tavassoly I; C2i Genomics Inc., New York, NY 10014, USA., Donenhirsh Z; C2i Genomics, Ltd., Haifa, Israel., White E; C2i Genomics Inc., New York, NY 10014, USA., Kandasamy R; C2i Genomics Inc., New York, NY 10014, USA., Alon U; C2i Genomics, Ltd., Haifa, Israel., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Jaensch C; Department of Surgery, Herning Regional Hospital, Denmark., Løve US; Department of Surgery, Viborg Regional Hospital, Denmark., Andersen PV; Department of Surgery, Odense University Hospital, Denmark., Thorlacius-Ussing O; Department of Surgical Gastroenterology, Aalborg University Hospital, Denmark., Iversen LH; Department of Clinical Medicine, Aarhus University, Denmark; Department of Surgery, Aarhus University Hospital, Denmark., Gotschalck KA; Department of Clinical Medicine, Aarhus University, Denmark; Department of Surgery, Randers Regional Hospital, Denmark., Zviran A; C2i Genomics Inc., New York, NY 10014, USA., Oklander B; C2i Genomics, Ltd., Haifa, Israel., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark. Electronic address: cla@clin.au.dk.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 211, pp. 114314. Date of Electronic Publication: 2024 Sep 11.

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.

Autor: Widman AJ; New York Genome Center, New York, NY, USA. widmana@mskcc.org.; Memorial Sloan Kettering Cancer Center, New York, NY, USA. widmana@mskcc.org., Shah M; New York Genome Center, New York, NY, USA., Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Halmos D; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Khamnei CC; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Øgaard N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Rajagopalan S; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Arora A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Deshpande A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Hooper WF; New York Genome Center, New York, NY, USA., Quentin J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Bass J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Zhang M; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Langanay T; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Andersen L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Steinsnyder Z; New York Genome Center, New York, NY, USA., Liao W; New York Genome Center, New York, NY, USA., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen SØ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Therkildsen C; Gastro Unit, Copenhagen University Hospital, Amager - Hvidovre Hospital, Hvidovre, Denmark., Sotelo J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Brand R; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Schiffman JS; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Shah RH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheng AP; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Maher C; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spain L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Krause K; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Frederick DT; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., den Brok W; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lohrisch C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Shenkier T; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Simmons C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Villa D; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Mungall AJ; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Moore R; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Zaikova E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Cerda V; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Kong E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lai D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Malbari MS; Weill Cornell Medicine, New York, NY, USA., Marton M; New York Genome Center, New York, NY, USA., Manaa D; New York Genome Center, New York, NY, USA., Winterkorn L; New York Genome Center, New York, NY, USA., Gelmon K; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Callahan MK; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boland G; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Potenski C; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saxena A; Weill Cornell Medicine, New York, NY, USA., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Imielinski M; New York Genome Center, New York, NY, USA.; Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA., Berger MF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aparicio S; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Altorki NK; Weill Cornell Medicine, New York, NY, USA., Postow MA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Robine N; New York Genome Center, New York, NY, USA., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.

Publikováno v: Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1655-1666. Date of Electronic Publication: 2024 Jun 14.

Ileus Management International (IMAGINE): protocol for a multicentre, observational study of ileus after colorectal surgery

Autor: Chapman, S. J., Arthur, T., Chan, E., Fomin, I., Ho, D., Morgan, S., Schachtel, M., Nabi, H., Vasko, P., Zabrak, R., Orhalmi, J., Larsen, H., Nors, J., Martensen, A., Paramasivam, R., Ravn, S., Venara, A., Frey, P. -E., Friedrich, M., Raedeker, L. B., Mihaljevic, A. L., Farina, V., Gavagna, L., Lorenzon, L., Pasquali, S., Pata, F., Pellino, G., Podda, M., Imioni, A., Gro, A., Zaffaroni, G., Schaeff, V., Tto, A., Ivins, A., Zolins, A., Jakubauskas, M., Poskus, T., van Dalen, A. S. H. M., ten Doesschate, S. F. H., van Elst, T. R., Kuiper, S. Z., Bemelman, W. A., Chu, M. J. J., Fagan, P., Wells, C. I., Bissett, I. P., Joao, A. A., Soares, A. S., Carneiro, C., Bautista, O., El Kasmi, Y., Perez-Ajates, S., Espin-Basamy, E., Clerc, D., Hubner, M., Aktas, M. K., Baki, B. E., Ozkan, B. B., Sen, A. Y., Yuksek, B., Gecim, E., Bath, M., Bhangu, A., Borakati, A., Fitzgerald, J., Glasbey, J. C. D., Golding, D., Goodson, R., Kamarajah, S., Khatri, C., Khaw, R., Mclean, K., Mills, E., Nepogodiev, D., Thakral, N., Vaughan-Shaw, P. G., Yasin, I., Pinkney, T. D., Blanco-Colino, R., Hodson, J.

Publikováno v: Colorectal disease, 20(1), O17-O25. Wiley-Blackwell
EuroSurg Collaborative 2018, ' Ileus Management International (IMAGINE) : protocol for a multicentre, observational study of ileus after colorectal surgery ', Colorectal Disease, vol. 20, no. 1, pp. O17-O25 . https://doi.org/10.1111/codi.13976
Colorectal Disease
Colorectal Disease, 2018, 20 (1), pp.O17-O25. ⟨10.1111/codi.13976⟩
Colorectal disease, vol. 20, no. 1, pp. O17-O25

International audience; AIM: The management of postoperative ileus following colorectal surgery remains controversial. It is the commonest complication after elective colorectal resection and is associated with an increased incidence of postoperative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596d2351106fe71032c6478d28fc8608
https://doi.org/10.1111/codi.13976